Efficacy and safety of glatiramer acetate in multiple sclerosis patients with allergic respiratory diseases

被引：0
|
作者：
Mallucci, G.
La Mantia, L.
Confalonieri, P. A.
Galgani, S.
Haggiag, S.
Lugaresi, A.
De Luca, G.
Solaro, C.
Trabucco, E.
Meola, G.
Robotti, M.
Cavaletti, G.
Frigeni, B.
Clerici, R.
Chiveri, L.
Bono, G.
Banfi, P.
Ambrosoni, E.
Mancardi, L.
Della Cava, F.
Balgera, R.
Bergamaschi, R.
机构：
[1] Fdn Ist Neurol Nazl C Mondino IRCCS, Pavia, Italy
[2] Fdn IRCCS Ist Neurol Carlo Besta, Milan, Italy
[3] Azienda Osped San Camillo Forlanini, Rome, Italy
[4] Policlin SS Annunziata, Chieti, Italy
[5] ASL3 Genovese, Genoa, Italy
[6] IRCCS Policlin San Donato, Milan, Italy
[7] Azienda Osped San Gerardo, Monza, Italy
[8] Osped Valduce, Como, Italy
[9] Osped Circolo Varese, Varese, Italy
[10] Fdn Macchi, Varese, Italy
[11] IRCCS Azienda Osped Univ San Martino, Genoa, Italy
[12] Azienda Osped Prov Lecco, Lecce, Italy
来源：
MULTIPLE SCLEROSIS JOURNAL | 2012年 / 18卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：428 / 429
页数：2
相关论文
共 50 条
  • [1] Lipoatrophy in patients with multiple sclerosis on glatiramer acetate
    Edgar, CM
    Brunet, DG
    Fenton, P
    McBride, EV
    Green, P
    CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 2004, 31 (01) : 58 - 63
  • [2] Equivalence of Glatiramer Acetate Generics With Branded Glatiramer Acetate in Efficacy and Cost for the Treatment of Multiple Sclerosis
    Bourdette, Dennis
    Hartung, Daniel
    JAMA NEUROLOGY, 2015, 72 (12) : 1411 - 1413
  • [3] Glatiramer acetate for multiple sclerosis
    La Mantia, Loredana
    Munari, Luca M.
    Lovati, Roberta
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2010, (05):
  • [4] Factors Associated with Glatiramer Acetate Efficacy in Japanese Multiple Sclerosis
    Tanaka, Eizo
    Watanabe, Mitsuru
    Fukumoto, Shoko
    Suezumi, Koki
    Matsushita, Takuya
    Isobe, Noriko
    Masaki, Katsuhisa
    MULTIPLE SCLEROSIS JOURNAL, 2023, 29 (07) : NP34 - NP35
  • [5] Evaluation of efficacy of glatiramer acetate treatment for multiple sclerosis in Japan
    Okamoto, T.
    Lin, Y.
    Araki, M.
    Sato, W.
    Takahashi, Y.
    Yamamura, T.
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 903 - 904
  • [6] Glatiramer acetate: long-term safety and efficacy in relapsing-remitting multiple sclerosis
    Boster, Aaron L.
    Ford, Corey C.
    Neudorfer, Orit
    Gilgun-Sherki, Yossi
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2015, 15 (06) : 575 - 586
  • [7] Panniculitis in multiple sclerosis patients treated with glatiramer acetate
    Sa, J
    Cordeiro, C
    MULTIPLE SCLEROSIS, 2005, 11 : S85 - S85
  • [8] Oral Teriflunomide or Placebo Added to Glatiramer Acetate for 6 Months in Patients with Relapsing Multiple Sclerosis: Safety and Efficacy Results
    Freedman, Mark
    Wolinsky, Jerry S.
    Frangin, Gerald A.
    Confavreux, Christian
    Comi, Giancarlo
    Byrnes, William J.
    Kappos, Ludwig
    Olsson, Tomas
    Miller, Aaron
    O'Connor, Paul
    NEUROLOGY, 2010, 74 (09) : A293 - A293
  • [9] Long-term treatment of multiple sclerosis patients with glatiramer acetate: clinical efficacy and anti-glatiramer acetate antibodies profile
    Teitelbaum, D.
    Brenner, T.
    Abramsky, O.
    Sicsic, C.
    Arnon, R.
    Karussis, D.
    MULTIPLE SCLEROSIS, 2006, 12 : S98 - S99
  • [10] Glatiramer acetate in multiple sclerosis: A review
    Ruggieri, Maddalena
    Avolio, Carlo
    Livrea, Paolo
    Trojano, Maria
    CNS DRUG REVIEWS, 2007, 13 (02): : 178 - 191
12345